Breaking Through "Ingredient Involution": How to Replace the "Concentration Arms Race" with "Compounding Logic"?

I. After the Ingredient Involution: "20% Vitamin C Serum," Where Do We Go Next?

The concentration arms race of skincare ingredients has been going on for nearly a decade. 10% Niacinamide, 20% Vitamin C, 2% Salicylic Acid, 1% Retinol... every single number was once a marketing bullet. However, this race is approaching its tipping point.

In 2025, a measurable shift has emerged in the skincare industry: the tide is receding on high-percentage active ingredients and quick-fix promises, replaced by a focus on barrier resilience, regenerative ingredients, microbiome balance, and longevity strategies. The direction for skincare in 2026 is already clear: becoming less aggressive and more strategic.

McKinsey's 2025 The State of Fashion and Beauty report data shows that 72% of consumers feel overwhelmed by the sheer number of new product launches, with younger consumers reporting the highest levels of fatigue.

This signal means the exact same thing for both brand owners and OEM factories: the era of stacking concentrations is ending, and the era of explaining logic is beginning.

II. Three "Involution" Traps of the "Concentration Arms Race"

Trap 1: Consumers' Skin "Cannot Tolerate It"

Multiple studies and dermatological reviews show that over-skincare actually leads to irritation, redness, acne, and even dermatitis. The rise of Skinimalism is a direct reaction to the multi-step skincare phenomenon of recent years, specifically targeting the risks of combining multiple active ingredients simultaneously—a practice that can disrupt the skin's natural balance and increase sensitivity.

Trap 2: High Formulation Homogenization Among Brands

AI and social media have turned everyone into an "amateur formulator," accelerating the popularization of ingredient knowledge but also exposing the predictable "cookie-cutter" nature of the market—different brands are essentially putting the same basic formulations into different bottles. The brands that stand out are those with original technology at their core, not those using marketing "complexes" to package the same raw materials into "proprietary" claims.

Trap 3: High Concentration ≠ High Efficacy

Biotechnology is already disrupting this logic: the biotech revolution has transformed not only the efficacy of skincare active ingredients but also their delivery methods. This enables companies to develop highly efficacious ingredients that require much lower concentrations in formulations than traditional actives—this precision not only enhances efficacy but also significantly reduces waste.

III. "Compounding Logic": Formulation Thinking That Makes 1+1 > 2

The core of compounding logic is not "stuffing more ingredients into one bottle," but consciously utilizing the synergistic relationships between ingredients to achieve higher overall efficacy at lower individual concentrations. Here are three classic compounding logic models:

Model 1: Mechanism Complementarity

Selecting ingredient combinations that act on different, non-overlapping targets for skin efficacy. Classic Case: Niacinamide (inhibits melanin transfer) × Arbutin (inhibits tyrosinase activity) × Vitamin C (reduces already oxidized melanin)—the three ingredients act on three different nodes of pigmentation formation. Compounded at concentrations below 3% each, the overall brightening efficacy is superior to any single-ingredient 10% high-concentration formula, with significantly lower irritation.

Model 2: Delivery Enhancement

Enhancing the bioavailability of low-concentration active ingredients in the skin by altering their delivery methods. Typical Application: 0.1% liposomal encapsulated retinol often has better skin penetration depth and sustained-release efficiency than 0.5% retinol in conventional dosage forms, while causing lower skin irritation and appealing to a broader tolerant population. Exosomes will be used in combination with signal peptides, carrier peptides, and soothing neuropeptides—this combination reduces downtime and helps maintain the "just-treated effect" for longer, representing the cutting-edge practice of compounding enhancement in 2026.

Model 3: Stability Synergy

Some active ingredients are highly unstable when they exist alone, but can mutually stabilize each other through specific compounding. Vitamin C (L-Ascorbic Acid) is extremely prone to oxidation in aqueous solutions, but when compounded with Vitamin E and Ferulic Acid, the three mutually stabilize each other, and the overall antioxidant activity can be increased by approximately 8 times. This is the most classic synergistic stabilization case in formulation science.

IV. Implications for OEM Factories: The Focus of Technical Capabilities Needs to Shift

Future cosmetics will be consciously developed—carefully considering ingredient synergy, regulatory compliance, cost efficiency, and real end-consumer needs. For the B2B sector, the conclusion is clear: market leadership will belong to those companies that treat ingredient selection and formulation development as core business strategies (rather than just production steps).

This means that an OEM factory that can help brand owners build "compounding logic" rather than simply providing "high-concentration formulas" will see its technical value repriced by the market in 2026 and beyond.

The shift in the focus of capabilities is specifically reflected in:

• From "Raw Material Stacking" to "Mechanism of Action Mapping": Being able to explain the targets of each ingredient and their synergistic relationships with other ingredients during the proposal stage.

• From "Single Concentration Validation" to "Compounding Efficacy Testing": Providing in vitro synergistic testing data for ingredient combinations, rather than just citing literature for single ingredients.

• From "Standardized Formula Library" to "Differentiated Compounding Solutions": Designing compounding strategies with genuine technical barriers for brands at different price points and market positionings.

Are you looking for a reliable Skincare factory?

Are you seeking a trusted partner to launch or scale your skin care line? At Deva Skincare,we specialize in developing safe formulations that combine barrier science with clean, compliant manufacturing.

Our R&D team and certified production facilities deliver turnkey OEM/ODM solutions tailored to your target market’s regulatory and consumer expectations.

By collaborating with Deva Skincare, you gain access to industry-leading expertise and innovative formulations that set your brand apart in the competitive global market. Contact us today to discover how we can help you succeed.